WENTWORTH KORY JAMES sold TRDA
April 1, 2026 · Form 4 insider transaction
WENTWORTH KORY JAMES sold 2,500 shares of Entrada Therapeutics, Inc. at $12.95 per share, a transaction worth $32.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,500
Price
$12.95
Total value
$32.4K
InsiderWENTWORTH KORY JAMES
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 2, 2026
Shares owned after119,010
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025.